A Late Juvenile Onset Type Metachromatic Leukodystrophy Case Presenting With Continuous Pseudobulbar Crying
Abstract
Keywords
Supporting Institution
Project Number
Thanks
References
- 1. Patil SA, Maegawa GH. Developing therapeutic approaches for metachromatic leukodystrophy. Drug Des Devel Ther 2013;7: 729–745.
- 2. Kliegman RM, Stanton BF, St Geme JW, Schor NF, Behrman RE. Neurodegenerative disorders of childhood. In: Kwon JM, editor. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: WB Saunders; 2011. p. 2072.
- 3. Luzi P, Rafi MA, Rao HZ, Wenger DA. Sixteen novel mutations in the arylsulfatase A gene causing metachromatic leukodystrophy. Gene 2013;530:323–328.
- 4. Wang RY, Bodamer OA, Watson MS, Wilcox WR. Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals. Genet Med 2011;13: 457–484.
- 5. Gieselmann V, Krageloh-Mann I. Metachromatic leukodystrophy e an update. Neuropediatrics 2010;41(1):1e6.
- 6. Kehrer C, Groeschel S, Kustermann-Kuhn B, et al. Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort. Orphanet J Rare Dis 2014;9(1):18.
- 7. Groeschel S, Dali C, Clas P, et al. Cerebral gray and white matter changes and clinical course in metachromatic leukodystrophy. Neurology. 2012;79: 1662- 1670.
- 8. Michael V Johnson Neurodegenerative disorders of childhood. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: W.B. Saunders Company; 2008: 592- 598.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Case Report
Authors
Aslı Bolayır
*
0000-0001-6566-3751
Türkiye
Publication Date
June 30, 2022
Submission Date
March 21, 2022
Acceptance Date
June 30, 2022
Published in Issue
Year 2022 Volume: 44 Number: 2